CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 240 enrolled
Drug / intervention
Fluoride toothpaste +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02753075
NCT02753075N/ACompleted
CompareCT.gov

A Clinical Study Investigating the Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity

GlaxoSmithKline·interventional·Posted Apr 27, 2016·Updated Aug 27, 2018

In Brief

A clinical study evaluating Experimental Oral Rinse 1, Experimental Oral Rinse 2, and 2 other interventions for Dentin Sensitivity. Completed, enrolled 240 participants across 1 site.

Detailed Summary

This study will investigate the longitudinal efficacy of two experimental oral rinses, one containing 1.5% weight/weight (w/w) dipotassium oxalate monohydride (KOX) /0 Parts per Million (ppm fluoride) and the other 2.0% w/w KOX /45ppm fluoride, for the relief of dentinal hypersensitivity (DH), compared to a placebo oral rinse, when used as an adjunct to twice daily brushing with a standard fluoride toothpaste.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Sensitivity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 27, 2016
Enrollment StartSep 8, 2015
Primary CompletionDec 1, 2015
Study CompletionDec 18, 2015
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 10.2 years ago

Interventions

Experimental Oral Rinse 1device

Oral rinse containing 1.5% w/w KOX, 0ppm F, pH 4.5

Experimental Oral Rinse 2device

Oral rinse containing 2.0% w/w KOX, 45ppm F, pH 4.5

Placebo Oral Rinseother

Oral rinse containing 0% w/w KOX 0ppm F, pH 4.5

Fluoride toothpastedrug

Oral rinse containing 1000ppm fluoride as sodium monofluorophosphate